Specialized Expertise
- Critical antibody reagent generation (ADA positive controls,
anti-idiotypes, anti-HCP) - ABSL2 vaccine challenge studies
- In vivo early safety studies in rodents
Capabilities
- Antibody reagents (polyclonal and monoclonal)
- Vaccine testing (discovery/POC phase –
immunogenicity and efficacy/challenge) - Early safety and pharmacokinetics